Various studies have shown that the percentage of pseudo-negative cytology diagnoses in cases of cervical cancer is between 17% to 56%. A review of those cases revealed that more than half of the mistakes was caused by deficient samples. Medibrush® has been designed to improve diagnostic reliability of the cytology samples. The samples obtained with MedibrushÒ contain an abundant quantity of endocervical cells, for precise and early detection of cervical neoplasy. The Medibrush® may be used only once. Features include 20 am length, individual sterilized packaging and Minimum thickness nylon filament.